Navigation Links
Life Technologies Announces Flagship PCR Instrument that Enables Cost-Effective, High-Throughput Screening Applications
Date:10/12/2011

point because of the nanoliter volumes required to conduct experiments on the QuantStudio™ 12K Flex OpenArray® plates – saving both reagent costs and precious samples.  Hands-on time to prepare the plates before each experiment is drastically reduced using a new workflow enabled on the fully automated OpenArray® AccuFill™ System, which eliminates manual OpenArray® plate handling and labor-intensive pipetting.

The QuantStudio™ 12K Flex system is also ideally suited for rapid, large-scale pathogen detection applications to quickly screen food samples during public health situations such as the recent Listeria and E. coli outbreaks in the United States and Germany, respectively.  For plant breeders, the ability to reliably link biomarkers to desired traits, such as drought-resistance and high yields, is expected to accelerate crop improvement efforts.

Flexible System

Life Technologies' new flagship PCR instrument eliminates the need to purchase multiple qPCR platforms that take up limited space in the laboratory. The QuantStudio™ 12K Flex system takes an all-in-one approach by accommodating any one of five different interchangeable blocks (OpenArray® plates, TaqMan® Array Card, 384-, 96 fast- and 96-well plates) to match the size and type of experiment.

"The QuantStudio 12K Flex system serves as an ideal complementary platform to next-generation sequencing," said Mark Stevenson, President and COO of Life Technologies. "While sequencing elucidates the unknown in a genome, the QuantStudio efficiently validates that data through broad screening of limited marker sets -- providing a powerful and flexible tool for researchers performing large-scale genotyping or gene expression experiments on a daily basis."

Life Technologies is hosting a series of events during the joint International Congress of H
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Roche Licenses Nanopore Sequencing Technologies from Arizona State University and Columbia University for Rapid, Affordable DNA Sequencing
2. BioStorage Technologies Expands Liquid Nitrogen Storage in Germany-based Biorepository Facility
3. Life Technologies Sets 3rd Quarter 2011 Earnings Release Date for Tuesday, October 25, 2011
4. Lifeline Biotechnologies and Depository Trust Company
5. Wound Management Technologies to Present at AdvaMed 2011; Conferences Featured Speakers to Include President George W. Bush & HHS Secretary Kathleen Sebelius
6. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results
7. Palatin Technologies, Inc. to Report Fiscal Year 2011 Fourth Quarter Results; Teleconference and Webcast to be held on September 22, 2011
8. Life Technologies Applauds Signing of Patent Reform Bill
9. Microban Medical Silver Antimicrobial Technologies for HCR Silicone Achieve 5 Log Reductions in Bacteria Growth and Prevent Biofilm Formation
10. Palatin Technologies, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference
11. BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... British Columbia , March 2, 2015 ... IMLFF), a clinical stage biopharmaceutical company specializing in ... that Craig Schneider , Chief Executive Officer, ... webcast at VirtualInvestorConferences.com. DATE: Thursday, March ... > click the red "register/ watch event now" ...
(Date:3/2/2015)... MENLO PARK, Calif. , March 2, 2015 /PRNewswire/ ... company in the emerging field of regenerative medicine, today ... year 2014 financial and operating results on Tuesday, March ... markets. The Company will host a conference call and ... Eastern / 1:30 p.m. Pacific to discuss the results ...
(Date:3/2/2015)... 2015 Outside GC, the leading provider ... addition of Debbie Casey as a member of the ... space. , Debbie has spent over 20 ... Fresenius Medical Care North America in both legal and ... to work with Outside GC’s growing list of healthcare ...
(Date:2/27/2015)... and SUMMERLAND, British Columbia , ... XON ), a leader in synthetic biology, ... acquire  Okanagan Specialty Fruits (OSF), the pioneering agricultural ... the world,s first non-browning apple. Through the acquisition, Intrexon ... that is more appetizing and convenient for consumers while ...
Breaking Biology Technology:InMed Pharmaceuticals to Present Investor Webcast March 5 2Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4
... Radiology Group Improves Physician Efficiency and Reduces Duplicative ... ... CHICAGO, Nov. 26 RSNA Booth #5924 -- Compressus ... in Illinois, announced today that ARC has improved physician,efficiency and ...
... Million for Q3 of 2007 versus $5.2 Million ... for Q3 of 2006, -- Gross profit increases 102% ... ... of $12.5 Million of Debt to Equity, BEIJING, Nov. 23 /Xinhua-PRNewswire/ -- China Biopharmaceuticals,Holdings, ...
... and PARIS, Nov. 23 Bristol-,Myers Squibb Company ... reported today,that they are terminating their license agreement ... investigation for the treatment of,advanced or metastatic bladder ... Pierre Fabre Medicament and licensed to Bristol-Myers Squibb,in ...
Cached Biology Technology:Diagnostic Turnaround Improved by 600% Through Interoperability 2Diagnostic Turnaround Improved by 600% Through Interoperability 3Diagnostic Turnaround Improved by 600% Through Interoperability 4China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 2China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 3China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 4China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 5China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 6China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 7
(Date:2/10/2015)... -- Alere Inc. (NYSE: ALR), a global leader in ... quarter ended December 31, 2014. Namal ... said, "We made substantial progress in the fourth ... in rapid diagnostics and delivering against our financial ... early January enabled us to substantially reduce our ...
(Date:2/5/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces ... ) as part of its 2015 marketing and branding ... its new consumer website for Wocketwallet.com earlier this month. ... NXT-ID said, "Our new corporate website naturally showcases our ...
(Date:2/5/2015)... 30, 2015  It is gratifying to see that ... for genomic science as a means to better understand ... treatment.  I was honored to participate in today,s White ... program. Since the 1980s my teams ... the first sequenced genome of a free living organism, ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... DALLAS Nov. 12, 2007 Human lung-cancer tumors grown ... treated with a synthetic compound that mimics the action of ... UT Southwestern Medical Center report. The findings, appearing in ... compound might one day be used in targeted therapies for ...
... On September 10, 2007, ConsumerLab.com issued ... contain label amounts of folic acid. One of these ... part of U. S. Pharmacopeias (USP) Dietary Supplement Verification ... to the report, USP studied the verified product to ...
... to stopping Alzheimers disease" A new research study from ... could offer a way to blunt or even prevent ... mice with a protein believed to play a key ... the vaccination showed a significant reduction in the build-up ...
Cached Biology News:Synthetic compound promotes death of lung-cancer cells, tumors 2Synthetic compound promotes death of lung-cancer cells, tumors 3Market testing of dietary supplements and drugs underscores value of USP's public health programs 2An Alzheimer's vaccine? 2An Alzheimer's vaccine? 3
...
...
... monoclonal [198C679.2.1] to Presenilin 2 Alzheimer's ... of the disease carry mutations in the ... precursor protein (APP). These disease-linked mutations result ... of amyloid-beta (main component of amyloid deposits ...
Human Presenilin-2 NTF Affinity Purified Polyclonal Ab...
Biology Products: